Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 EUR | -0.83% | -3.90% | -45.99% |
04/04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
03/04 | AB Science: reconsideration possible for masitinib in ALS | CF |
- Stock Market
- Equities
- AB Stock
- News AB Science
- Press Releases